Over the past three years Johnson & Johnson has spent more than $3.4 billion litigating cases involving its medical devices. While the company has suffered some setbacks in the courtroom, earlier this week it got some good news when it again defeated an early test case involving one of its most embattled products.
The U.S. Court of Appeals for the Fourth Circuit ruled Monday that the first of thousands of pelvic mesh cases against J&J to go to trial was properly dismissed for lack of evidence. In an unpublished opinion, the Fourth Circuit upheld lower court rulings tossing the plaintiff’s failure to warn and design defect claims.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
